Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools or diarrhoea after stopping Wegovy are reported by some people and, in most cases, settle on their own within a few days to two weeks as the body readjusts. Semaglutide slows how quickly food moves through the gut; when that effect lifts, digestion can temporarily speed up. If you're reading this feeling frustrated or a little worried, that's entirely understandable — bowel changes are uncomfortable and it's not always clear what's normal. These are prescription-only medicines, and any decision about stopping, restarting or managing side effects should be made alongside your prescriber rather than unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works partly by slowing gastric emptying, the rate at which your stomach passes food into the small intestine. Over weeks or months on the medicine, your digestive system adapts to that slower rhythm. When you stop, that brake is released. For some people the gut overcorrects temporarily, moving food through faster than usual, which produces loose stools or more frequent bowel movements.
This isn't unique to Wegovy: the same mechanism underlies the nausea and diarrhoea some people get when they first start taking Wegovy, just running in the opposite direction. The body is calibrating again. For most people the adjustment takes a few days; for others it can stretch to one or two weeks. A small number find symptoms linger a little longer, particularly if they were on a higher maintenance dose before stopping.
Diet also plays a role. Appetite often returns after stopping, and eating more (especially richer or higher-fat food) can compound loose stools while the gut is still settling. Staying hydrated and reintroducing food gradually tends to help. It is also worth knowing that nausea after stopping Wegovy can accompany these digestive changes, as the gut adjusts to the absence of the medicine. The NHS medicines information for semaglutide notes gastrointestinal symptoms as an expected class effect of GLP-1 medicines.
Most people find their bowel habits normalise within a few days to two weeks of their last dose. Semaglutide has a half-life of around one week, meaning it takes several weeks to clear the body completely, so mild GI changes in the first fortnight are physiologically predictable rather than alarming.
If symptoms persist beyond two weeks or are severe from the outset, that warrants attention. Prolonged diarrhoea is not a typical feature of stopping Wegovy and may have a separate cause worth investigating. For a clearer picture of how long Wegovy's effects last after the last dose, the timeline depends partly on which dose you were on and how long you had been taking it. If nausea is also a concern alongside your bowel symptoms, our page on how long nausea lasts after stopping Wegovy gives a more detailed breakdown of what to expect.
One practical note: keep fluid intake up. Diarrhoea that continues for more than a day or two can cause dehydration even when the individual episodes seem mild. If you notice dark urine, dizziness on standing, or feel unusually thirsty, treat that as a prompt to contact your GP or prescriber rather than waiting it out.
Most post-discontinuation bowel changes do not need emergency attention. The following, however, do:
Seek same-day medical assessment if you experience: diarrhoea accompanied by severe abdominal pain (particularly pain that spreads to your back) with or without vomiting. This combination can indicate acute pancreatitis, which is a known though infrequent serious side effect of GLP-1 medicines. The MHRA highlighted pancreatitis as a risk warranting urgent attention in its January 2026 Drug Safety Update on GLP-1 medicines.
Also seek prompt help for: signs of significant dehydration (dizziness, reduced urination, confusion), blood in stools, fever alongside diarrhoea, or symptoms that worsen rather than improve after the first week. These are not expected features of stopping Wegovy and need to be assessed on their own merits.
If you're uncertain whether what you're experiencing falls within normal range, contacting your prescriber directly is always the right call. The broader picture of side effects after stopping Wegovy covers additional symptoms beyond the gut that are worth knowing about.
The evidence on tapering versus abrupt discontinuation of semaglutide specifically for managing GI side effects is limited. What's clear from the medicine's pharmacology is that the longer half-life of semaglutide (roughly seven days) provides a natural, gradual washout even when a patient simply stops taking it, so the body is rarely hit with an instant withdrawal. That said, clinicians sometimes recommend a gradual reduction in dose before stopping, partly to manage GI effects and partly to allow psychological and behavioural adjustment.
If you stopped Wegovy without discussing it with your prescriber first, it's worth a conversation, not to restart if that's not right for you, but to flag any symptoms you're experiencing and get proper follow-up. Our overview of Wegovy as a treatment covers the full clinical picture, and the consultation page is the starting point if you want a prescriber's view on your specific situation. Semaglutide (Wegovy) is a prescription-only medicine, and the prescriber who authorised your treatment is the right person to support any decision to stop or change it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.